Sponsorship and Funding for Gene Therapy Trials in the United States

Zachary Kassir; Ameet Sarpatwari; Brian Kocak; Courtney C Kuza; Walid F Gellad

doi:10.1001/jama.2019.22214

Sponsorship and Funding for Gene Therapy Trials in the United States

JAMA. 2020 Mar 3;323(9):890-891. doi: 10.1001/jama.2019.22214.

Authors

Zachary Kassir¹, Ameet Sarpatwari², Brian Kocak¹, Courtney C Kuza³, Walid F Gellad³

Affiliations

¹ University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
² Program on Regulation, Therapeutics, and Law (PORTAL), Brigham and Women's Hospital, Boston, Massachusetts.
³ Center for Pharmaceutical Policy and Prescribing, University of Pittsburgh, Pittsburgh, Pennsylvania.

Abstract

This study characterizes government, academia, and private funding for gene therapy trials in the United States by technology type and therapeutic and disease area.

MeSH terms

Clinical Trials as Topic / economics*
Conflict of Interest
Drug Industry
Financing, Government
Genetic Therapy / economics*
Humans
National Institutes of Health (U.S.)
Research Support as Topic / statistics & numerical data*
United States